JLE

Bulletin du Cancer

MENU

Aging and geriatric oncology Volume 95, supplement 8, FMC Oncogériatrie

Authors
Service de gériatrie, Hôpital européen Georges Pompidou, 20, rue Leblanc, 75015 Paris

Chronologic age is not the exclusive factor for therapeutic decision, specially because life expectancy in very old age remains significant. Evaluation of health, autonomy and diseases are more important. Health status in very old age results from genetic factors, life-course and aging. The later may be understood as an adaptative process in response to life-course. These factors lead to frailty, whose evaluation is essential to high quality care in elderly patients. This evaluation must be multidimensional and lead to a care-plan. Even no randomized controlled trial had demonstrated benefits of geriatric intervention in cancer elderly patients, there is a high probability that improvement in mortality, morbidity, autonomy and quality of care may be obtained by strong collaboration of oncologists and geriatricians.